IN2014MN02248A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02248A IN2014MN02248A IN2248MUN2014A IN2014MN02248A IN 2014MN02248 A IN2014MN02248 A IN 2014MN02248A IN 2248MUN2014 A IN2248MUN2014 A IN 2248MUN2014A IN 2014MN02248 A IN2014MN02248 A IN 2014MN02248A
- Authority
- IN
- India
- Prior art keywords
- compositions
- present
- guar
- sorbitol
- drug delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261642901P | 2012-05-04 | 2012-05-04 | |
PCT/US2013/039487 WO2013166399A1 (en) | 2012-05-04 | 2013-05-03 | Ophthalmic compositions with improved dessication protection and retention |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02248A true IN2014MN02248A (es) | 2015-07-24 |
Family
ID=48464107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2248MUN2014 IN2014MN02248A (es) | 2012-05-04 | 2013-05-03 |
Country Status (19)
Country | Link |
---|---|
US (6) | US20130296264A1 (es) |
EP (1) | EP2844226B1 (es) |
KR (1) | KR102076033B1 (es) |
CN (2) | CN104379131A (es) |
AR (1) | AR090930A1 (es) |
AU (1) | AU2013256144B2 (es) |
BR (1) | BR112014027582B1 (es) |
CA (1) | CA2872622C (es) |
DK (1) | DK2844226T3 (es) |
ES (1) | ES2761373T3 (es) |
IN (1) | IN2014MN02248A (es) |
MX (1) | MX362266B (es) |
PH (1) | PH12014502571A1 (es) |
PL (1) | PL2844226T3 (es) |
PT (1) | PT2844226T (es) |
RU (1) | RU2659207C2 (es) |
UA (1) | UA113434C2 (es) |
WO (1) | WO2013166399A1 (es) |
ZA (1) | ZA201408490B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
US10245324B2 (en) * | 2014-10-31 | 2019-04-02 | Johnson & Johnson Consumer Inc. | Ophthalmic composition |
CN105311042B (zh) * | 2015-09-07 | 2019-04-12 | 广州国宇医药科技有限公司 | 一种糖醇组合物在制备治疗干眼症的药物中的应用 |
PT3352766T (pt) | 2015-09-24 | 2022-03-22 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e processos para o seu uso |
US10632202B2 (en) | 2016-03-04 | 2020-04-28 | Johnson & Johnson Consumer Inc. | Preservative containing compositions |
TW201938141A (zh) * | 2018-02-21 | 2019-10-01 | 瑞士商諾華公司 | 基於脂質的眼用乳劑 |
TWI757773B (zh) * | 2019-06-28 | 2022-03-11 | 瑞士商愛爾康公司 | 眼用組成物 |
CN114191378A (zh) * | 2021-11-23 | 2022-03-18 | 温州医科大学附属眼视光医院 | 一种地夸磷索缓释凝胶及其制备方法与应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09227385A (ja) * | 1996-02-29 | 1997-09-02 | Ofutekusu:Kk | 眼手術用補助剤 |
EP1348427B1 (en) | 1997-07-29 | 2008-04-09 | Alcon Laboratories, Inc. | Ophthalmic compositions containing galactomannan polymers and borate |
AU2004249137B2 (en) * | 2003-06-13 | 2010-03-11 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
JP5431965B2 (ja) * | 2007-02-09 | 2014-03-05 | アルコン,インコーポレイテッド | 3種のポリマーの相乗的組み合わせを含む眼科用組成物 |
US20090036554A1 (en) * | 2007-08-01 | 2009-02-05 | Burke Susan E | Ophthalmic compositions comprising a terpene compound |
US9096819B2 (en) * | 2008-01-31 | 2015-08-04 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer |
WO2009132294A1 (en) * | 2008-04-26 | 2009-10-29 | Alcon Research, Ltd. | Polymeric artificial tear system |
US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
EP2566447B1 (en) * | 2010-05-05 | 2020-07-15 | Alcon Inc. | Stabilized ophthalmic galactomannan formulations |
-
2013
- 2013-03-05 UA UAA201412705A patent/UA113434C2/uk unknown
- 2013-05-03 AU AU2013256144A patent/AU2013256144B2/en active Active
- 2013-05-03 CA CA2872622A patent/CA2872622C/en active Active
- 2013-05-03 US US13/886,788 patent/US20130296264A1/en not_active Abandoned
- 2013-05-03 IN IN2248MUN2014 patent/IN2014MN02248A/en unknown
- 2013-05-03 WO PCT/US2013/039487 patent/WO2013166399A1/en active Application Filing
- 2013-05-03 ES ES13723623T patent/ES2761373T3/es active Active
- 2013-05-03 MX MX2014013444A patent/MX362266B/es active IP Right Grant
- 2013-05-03 KR KR1020147032805A patent/KR102076033B1/ko active IP Right Grant
- 2013-05-03 RU RU2014148758A patent/RU2659207C2/ru active
- 2013-05-03 PL PL13723623T patent/PL2844226T3/pl unknown
- 2013-05-03 EP EP13723623.8A patent/EP2844226B1/en active Active
- 2013-05-03 AR ARP130101515A patent/AR090930A1/es unknown
- 2013-05-03 CN CN201380031008.8A patent/CN104379131A/zh active Pending
- 2013-05-03 DK DK13723623.8T patent/DK2844226T3/da active
- 2013-05-03 BR BR112014027582-3A patent/BR112014027582B1/pt active IP Right Grant
- 2013-05-03 PT PT137236238T patent/PT2844226T/pt unknown
- 2013-05-03 CN CN201811311427.8A patent/CN109157539A/zh active Pending
-
2014
- 2014-11-19 ZA ZA2014/08490A patent/ZA201408490B/en unknown
- 2014-11-19 PH PH12014502571A patent/PH12014502571A1/en unknown
-
2017
- 2017-02-01 US US15/421,513 patent/US20170136057A1/en not_active Abandoned
-
2019
- 2019-12-19 US US16/721,443 patent/US10828320B2/en active Active
-
2020
- 2020-10-01 US US17/060,343 patent/US11376275B2/en active Active
-
2022
- 2022-05-19 US US17/664,143 patent/US11672820B2/en active Active
-
2023
- 2023-05-17 US US18/319,196 patent/US20230285443A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02248A (es) | ||
MX2012012826A (es) | Formulaciones de galactomanana oftalmicas estabilizadas. | |
MX2023000320A (es) | Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion. | |
AR112286A2 (es) | Sistema polimérico de lágrimas artificiales | |
MX2020007227A (es) | Nanoparticulas farmaceuticas que muestran la mejora del transporte de la mucosa. | |
WO2012075086A3 (en) | Fabric care composition | |
GB201106743D0 (en) | Novel compounds | |
WO2013040242A3 (en) | Dermal filler compositions for fine line treatment | |
PH12014502840A1 (en) | Vaccine compositions | |
EP2600834A4 (en) | COLLAGEN IMPLANTS FOR THE SUSTAINABLE DELIVERY OF MEDICAMENTS | |
NZ739588A (en) | Enhanced stability of novel liquid compositions | |
MX359884B (es) | Derivado del acido hialuronico con aminoacido y grupo esterilo introducido en este. | |
MX2013004981A (es) | Composiciones y metodos para la administracion de agentes terapeuticos. | |
MX2013004061A (es) | Analogos de ciclosporina. | |
SG194175A1 (en) | Polymer conjugated prostaglandin analogues | |
GB2492935A (en) | Conjugated blood coagulation factor VIII | |
MX2013002422A (es) | Sales de lorcaserina con acidos opticamente activos. | |
WO2013171764A3 (en) | Ophthalmic formulations | |
MX2013004693A (es) | Composiciones de aripiprazol y metodos para su suministro transdermico. | |
MX2013004062A (es) | Analogos de ciclosporina. | |
MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
PH12015500585A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
PH12015500704A1 (en) | Pharmaceutical composition comprising rebamipide | |
MX2015007794A (es) | Suministro transmucosal de acetato de glatiramer mediante parches orales. | |
EP2782590A4 (en) | BIODEGRADABLE AND MEDIUM-RADIATED STERILIZED MEDICAMENTAL COMPOSITIONS |